Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Eric: Gotcha
Potential injection site reactions Compounded formulations sometimes cause more injection site irritation than single-ingredient products
TB-500 is the rate-limiting component due to its larger size
Regulatory Status AOD-9604 is not FDA-approved for any medical use and is listed by the FDA as a bulk drug substance that may present safety risks. Clinical development was halted after Phase IIb trials failed to meet efficacy endpoints. Summary AOD-9604 is a synthetic analog of the HGH 177191 fragment developed for fat-metabolism research
US$ 28.35
US$ 27.42
US$ 29.23
